Ventus Therapeutics raises $140m to advance drug discovery platform
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Feb 22
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…
23 Dec 21
The acquisition will enable Novartis to add Gyroscope’s investigational gene therapy, GT005, to its portfolio
17 Jun 21
Allcyte’s platform anticipates the activity of cancer treatments using AI to analyse the activity of drugs in live…
20 May 21
The collaboration will deploy AI to advance the discovery of small molecule therapeutic drug candidates in multiple therapeutic…
04 May 21
The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
28 Apr 21
Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…
04 Mar 21
Exscientia intends to use proceeds from the financing round to further advance AI drug discovery platform and portfolio
11 Feb 21
The collaboration will focus on a specific neuroinflammatory pathway associated with the development of AD
11 Dec 20
The acquisition will help expand Boehringer Ingelheim’s focus on patients with difficult-to-treat solid tumours
10 Dec 20
Exscientia intends to use its AI-based Centaur platforms for genome scale AI-drug discovery and address critical global health…